<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yestino - The Signal · GE HealthCare</title><link>https://yestino.com/entities/ge-healthcare-19b9ca</link><description>Every event involving GE HealthCare</description><language>en</language><atom:link href="https://yestino.com/entities/ge-healthcare-19b9ca/feed.xml" rel="self" type="application/rss+xml"/><item><title>GE HealthCare is buying radiopharmaceutical maker Sofie Biosciences for $945 million</title><link>https://yestino.com/events/ge-healthcare-is-buying-radiopharmaceutical-maker-sofie-bios-b7cb90</link><guid isPermaLink="true">https://yestino.com/events/ge-healthcare-is-buying-radiopharmaceutical-maker-sofie-bios-b7cb90</guid><pubDate>Mon, 05 Oct 2026 13:23:03 GMT</pubDate><description>The deal expands GE HealthCare&apos;s pharmaceutical diagnostics footprint and adds a late-stage cancer imaging tracer to its pipeline
Sources: Quartz</description></item></channel></rss>